FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096906921> ?p ?o ?g. }

• W2096906921 endingPage "2770" @default.
• W2096906921 startingPage "2760" @default.
• W2096906921 abstract "BACKGROUND Histone deacetylase inhibitors (HDACIs) can inhibit proliferation, stimulate apoptosis, and induce cell cycle arrest in malignant cells. METHODS The authors investigated the effects of four HDACIs on nine ovarian carcinoma cell lines in vitro and in vivo. Ovarian carcinoma cells were treated with a variety of HDACIs, and their effects on cell growth, the cell cycle, apoptosis, and related events were investigated. The ability of valproic acid (VPA) to inhibit the growth of ovarian tumors in immunodeficient mice was also assessed. RESULTS Clonogenic assays showed that all ovarian carcinoma cell lines were sensitive to the growth-inhibitory effects of the HDACIs. Cell cycle analysis indicated that their exposure to HDACIs decreased the proportion of cells in S phase and increased the proportion of cells in the G0/G1 and/or G2/M phases of the cell cycle. Terminal deoxynucleotidyltransferase-mediated uridine triphosphate end-labeling assays demonstrated that HDACIs induced apoptosis, which occurred in concert with alterations in the expression of genes related to apoptosis, cell growth, and malignant phenotype, including the activation of caspase-9 and caspase-3. Chromatin immunoprecipitation analysis revealed a notable increase in levels of acetylated histones associated with the p21 promoter after treatment with suberoylanilide bishydroxamine. In addition, in experiments involving nude mice, VPA significantly inhibited human ovarian tumor growth without toxic side effects. CONCLUSIONS The results of the current study suggest that HDACIs may be particularly effective in the treatment of ovarian tumors. Cancer 2004. © 2004 American Cancer Society." @default.
• W2096906921 created "2016-06-24" @default.
• W2096906921 creator A5003152895 @default.
• W2096906921 creator A5030377560 @default.
• W2096906921 creator A5038296421 @default.
• W2096906921 creator A5061189755 @default.
• W2096906921 creator A5082903377 @default.
• W2096906921 creator A5086185811 @default.
• W2096906921 date "2004-01-01" @default.
• W2096906921 modified "2023-10-11" @default.
• W2096906921 title "Human ovarian carcinoma cells: Histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis" @default.
• W2096906921 cites W1563624749 @default.
• W2096906921 cites W1981752846 @default.
• W2096906921 cites W1991172705 @default.
• W2096906921 cites W1993943690 @default.
• W2096906921 cites W2002698073 @default.
• W2096906921 cites W2026036357 @default.
• W2096906921 cites W2032555434 @default.
• W2096906921 cites W2039075718 @default.
• W2096906921 cites W2054696920 @default.
• W2096906921 cites W2078619188 @default.
• W2096906921 cites W2081490747 @default.
• W2096906921 cites W2104788426 @default.
• W2096906921 cites W2104805076 @default.
• W2096906921 cites W2107733280 @default.
• W2096906921 cites W2111420633 @default.
• W2096906921 cites W2121296685 @default.
• W2096906921 cites W2135085078 @default.
• W2096906921 cites W2135373289 @default.
• W2096906921 cites W2159287501 @default.
• W2096906921 cites W2164290357 @default.
• W2096906921 cites W2166082601 @default.
• W2096906921 cites W2167118090 @default.
• W2096906921 cites W2171074974 @default.
• W2096906921 doi "https://doi.org/10.1002/cncr.20709" @default.
• W2096906921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15536623" @default.
• W2096906921 hasPublicationYear "2004" @default.
• W2096906921 type Work @default.
• W2096906921 sameAs 2096906921 @default.
• W2096906921 citedByCount "103" @default.
• W2096906921 countsByYear W20969069212012 @default.
• W2096906921 countsByYear W20969069212013 @default.
• W2096906921 countsByYear W20969069212014 @default.
• W2096906921 countsByYear W20969069212015 @default.
• W2096906921 countsByYear W20969069212016 @default.
• W2096906921 countsByYear W20969069212017 @default.
• W2096906921 countsByYear W20969069212018 @default.
• W2096906921 countsByYear W20969069212019 @default.
• W2096906921 countsByYear W20969069212020 @default.
• W2096906921 countsByYear W20969069212021 @default.
• W2096906921 crossrefType "journal-article" @default.
• W2096906921 hasAuthorship W2096906921A5003152895 @default.
• W2096906921 hasAuthorship W2096906921A5030377560 @default.
• W2096906921 hasAuthorship W2096906921A5038296421 @default.
• W2096906921 hasAuthorship W2096906921A5061189755 @default.
• W2096906921 hasAuthorship W2096906921A5082903377 @default.
• W2096906921 hasAuthorship W2096906921A5086185811 @default.
• W2096906921 hasBestOaLocation W20969069211 @default.
• W2096906921 hasConcept C104317684 @default.
• W2096906921 hasConcept C105696609 @default.
• W2096906921 hasConcept C117262875 @default.
• W2096906921 hasConcept C119157956 @default.
• W2096906921 hasConcept C121608353 @default.
• W2096906921 hasConcept C126322002 @default.
• W2096906921 hasConcept C190283241 @default.
• W2096906921 hasConcept C2776202225 @default.
• W2096906921 hasConcept C2778305200 @default.
• W2096906921 hasConcept C2780427987 @default.
• W2096906921 hasConcept C29537977 @default.
• W2096906921 hasConcept C3019054536 @default.
• W2096906921 hasConcept C502942594 @default.
• W2096906921 hasConcept C54355233 @default.
• W2096906921 hasConcept C55493867 @default.
• W2096906921 hasConcept C62112901 @default.
• W2096906921 hasConcept C64927066 @default.
• W2096906921 hasConcept C71924100 @default.
• W2096906921 hasConcept C81885089 @default.
• W2096906921 hasConcept C86803240 @default.
• W2096906921 hasConceptScore W2096906921C104317684 @default.
• W2096906921 hasConceptScore W2096906921C105696609 @default.
• W2096906921 hasConceptScore W2096906921C117262875 @default.
• W2096906921 hasConceptScore W2096906921C119157956 @default.
• W2096906921 hasConceptScore W2096906921C121608353 @default.
• W2096906921 hasConceptScore W2096906921C126322002 @default.
• W2096906921 hasConceptScore W2096906921C190283241 @default.
• W2096906921 hasConceptScore W2096906921C2776202225 @default.
• W2096906921 hasConceptScore W2096906921C2778305200 @default.
• W2096906921 hasConceptScore W2096906921C2780427987 @default.
• W2096906921 hasConceptScore W2096906921C29537977 @default.
• W2096906921 hasConceptScore W2096906921C3019054536 @default.
• W2096906921 hasConceptScore W2096906921C502942594 @default.
• W2096906921 hasConceptScore W2096906921C54355233 @default.
• W2096906921 hasConceptScore W2096906921C55493867 @default.
• W2096906921 hasConceptScore W2096906921C62112901 @default.
• W2096906921 hasConceptScore W2096906921C64927066 @default.
• W2096906921 hasConceptScore W2096906921C71924100 @default.
• W2096906921 hasConceptScore W2096906921C81885089 @default.
• W2096906921 hasConceptScore W2096906921C86803240 @default.

• next